 | Win 55212-2 | IC50 | 1.1 [1], 3.4 [2], 8.9 [3], 15.7 [4] |
 | Rimonabant | IC50 | 600.0 [1], 9100.0 [2] |
| Rimonabant | Ki | 815.0 [1] |
 | 5-(1,1-Dimethylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]phenol | IC50 | 0.82 [1], 1.3 [2] |
 | 5-(4-Chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-(1,3,3-trimethyl-2-bicyclo[2.2.1]heptanyl)pyrazole-3-carboxamide | IC50 | 3.16 [1] |
 | Dronabinol | IC50 | 9.5 [1] |
 | (6AR,10AR)-3-(1,1-Dimethylbutyl)-6A,7,10,10A-tetrahydro-6,6,9-trimethyl-6H-dibenzo[B,D]pyran | IC50 | 550.0 [1] |
 | CID 3081355 | IC50 | 19.95 [1], 760.0 [2] |
 | Anandamide | Ki | 160.0 [1], 371.0 [2] |
 | (6-Iodo-2-methyl-1-(2-morpholinoethyl)-1H-indol-3-yl)(4-methoxyphenyl)methanone | IC50 | 7200.0 [1] |
 | (2-Iodo-5-nitrophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)methanone | IC50 | 3.4 [1] |
 | (2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone | Ki | 36.0 [1] |
 | Ibipinabant | IC50 | 1100.0 [1] |
 | (Inverted exclamation markA)-SLV319 | IC50 | 5000.0 [1] |
| (Inverted exclamation markA)-SLV319 | Ki | 1000.0 [1], 125892.54 [2] |
 | 3-Quinolinecarboxamide, N-(1,3-benzodioxol-5-ylmethyl)-1,2-dihydro-7-methoxy-2-oxo-8-(pentyloxy)- | IC50 | 25.12 [1], 644.0 [2] |
| 3-Quinolinecarboxamide, N-(1,3-benzodioxol-5-ylmethyl)-1,2-dihydro-7-methoxy-2-oxo-8-(pentyloxy)- | Ki | 0.09 [1], 1.55 [2], 35.9 [3], 130.0 [4] |
 | (1-(2-Morpholinoethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | IC50 | 0.77 [1] |
| (1-(2-Morpholinoethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | Ki | 4.37 [1], 4.4 [2], 4.6 [3] |
 | delta8-Tetrahydrocannabinol | Ki | 12.0 [1], 25.0 [2], 38.9 [3] |
 | Taranabant | IC50 | 285.0 [1], 290.0 [2], 1170.0 [3] |
| Taranabant | Ki | 290.0 [1] |
 | (6Ar,10aR)-6,6,9-trimethyl-3-(2-phenylpropan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | Ki | 0.91 [1] |
 | [(1S,4S,5S)-4-[2,6-Dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methanol | Ki | 11.2 [1], 22.7 [2] |
 | 1-Naphthalenyl[4-(pentyloxy)-1-naphthalenyl]methanone | IC50 | 98.0 [1], 5300.0 [2] |
| 1-Naphthalenyl[4-(pentyloxy)-1-naphthalenyl]methanone | Ki | 19.0 [1] |
 | (3-Benzyl-3-methyl-2,3-dihydrobenzofuran-6-yl)(piperidin-1-yl)methanone | Ki | 422.0 [1] |
 | 2-[[1-(Cyclohexylmethyl)-2-oxo-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine-3-carbonyl]amino]-2-methylpropanoic acid | Ki | 349.0 [1], 349.14 [2] |
 | 6-Methoxy-5-(2-morpholin-4-ylethyl)-2-[(1S,2S,4R)-1,3,3-trimethyl-2-bicyclo[2.2.1]heptanyl]pyrido[4,3-b]indol-1-one | Ki | 1.0 [1] |
 | 1-[(4-Fluorophenyl)methyl]-N-(4-methylcyclohexyl)-2-oxo-1,8-naphthyridine-3-carboxamide | IC50 | 1.37 [1] |
| 1-[(4-Fluorophenyl)methyl]-N-(4-methylcyclohexyl)-2-oxo-1,8-naphthyridine-3-carboxamide | Ki | 0.7 [1], 0.9 [2], 9.0 [3] |
 | (2S)-2-Cyclohexyl-2-[[1-(cyclohexylmethyl)-2-oxo-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine-3-carbonyl]amino]acetic acid | IC50 | 51.0 [1] |
| (2S)-2-Cyclohexyl-2-[[1-(cyclohexylmethyl)-2-oxo-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine-3-carbonyl]amino]acetic acid | Ki | 111.0 [1] |
 | 6-Bromo-1-[(4-fluorophenyl)methyl]-N-(4-methylcyclohexyl)-2-oxo-1,8-naphthyridine-3-carboxamide | IC50 | 0.72 [1], 31.6 [2] |
| 6-Bromo-1-[(4-fluorophenyl)methyl]-N-(4-methylcyclohexyl)-2-oxo-1,8-naphthyridine-3-carboxamide | Ki | 0.12 [1], 1.12 [2] |
 | 2-Arachidonoylglycerol | Ki | 1300.0 [1], 1400.0 [2] |
 | Nabilone | Ki | 1.84 [1], 17.6 [2] |
 | N-(4-Hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide | Ki | 1000.0 [1], 1300.0 [2] |
 | 1-Pentyl-3-(1-naphthoyl)indole | Ki | 2.9 [1], 6.31 [2] |
 | [(1R,4S,5R)-4-[2,6-Dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methanol | Ki | 22.7 [1] |
 | HU-308 | IC50 | 117.0 [1] |
| HU-308 | Ki | 11.2 [1], 14.0 [2] |
 | Noladin ether | Ki | 1000.0 [1], 3000.0 [2] |
 | Psncbam 1 | IC50 | 10000.0 [1] |
| Psncbam 1 | Ki | 10000.0 [1] |
 | 1-(2,4-Dichlorophenyl)-6-methyl-N-(1-piperidinyl)-4H-indeno[1,2-c]pyrazole-3-carboxamide | Ki | 0.04 [1] |
 | 12-Chloro-3-(2,4-dichlorophenyl)-N-piperidin-1-yl-3,4-diazatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaene-5-carboxamide | Ki | 20.0 [1], 21.0 [2], 85.2 [3] |
 | (6Ar,10aR)-3-(1-adamantyl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | Ki | 52.0 [1], 19054607.18 [2] |
 | N-(3-(2-Methoxyethyl)-4,5-dimethylthiazol-2(3H)-ylidene)-2,2,3,3-tetramethylcyclopropanecarboxamide | Ki | 0.64 [1] |
 | 1-Butanesulfonic acid, 4,4,4-trifluoro-, 3-(2-cyano-3-(trifluoromethyl)phenoxy)phenyl ester | Ki | 45.5 [1] |
 | (6Ar,10aR)-6,6,9-trimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | Ki | 0.49 [1] |
 | 1-[[6-Ethyl-1-[(4-fluorophenyl)methyl]-5-methyl-2-oxopyridine-3-carbonyl]amino]cyclohexane-1-carboxylic acid | IC50 | 24.0 [1] |
| 1-[[6-Ethyl-1-[(4-fluorophenyl)methyl]-5-methyl-2-oxopyridine-3-carbonyl]amino]cyclohexane-1-carboxylic acid | Ki | 36.0 [1] |
 | CID 5311216 | Ki | 11.8 [1], 19.4 [2] |
 | [4-(3,5-Dichlorophenyl)-3,5-dihydroxyphenyl]-phenylmethanone | Ki | 2.94 [1], 121.3 [2] |
 | (6Ar,10aR)-1-methoxy-6,6,9-trimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene | Ki | 6.4 [1], 20.0 [2] |
 | N3-(1-Adamantyl)-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxamide | Ki | 4.7 [1], 16.4 [2] |
 | N-(Adamant-1-yl)-6-isopropyl-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxamide | Ki | 6.3 [1] |
 | 3-(1,1-Dimethyl-heptyl)-6,6,9-trimethyl-6H-benzo[c]chromen-1-ol | Ki | 1.5 [1], 2.24 [2] |
 | Methanone, (4-methyl-1-naphthalenyl)(1-propyl-1H-indol-3-yl)- | Ki | 6.09 [1], 6.1 [2] |
 | 1-[2-(Morpholin-4-yl)ethyl]-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-4-amine | Ki | 32.0 [1], 32.36 [2] |
 | 6-Methyl-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole | Ki | 0.15 [1], 0.2 [2] |
 | 1-(Oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-6-ol | Ki | 8.3 [1], 8.5 [2], 8.51 [3] |
 | 7-Methoxy-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole | Ki | 0.1 [1], 0.12 [2], 0.13 [3] |
 | 5-(Benzyloxy)-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole | Ki | 1.26 [1], 1.3 [2] |
 | 5-Methoxy-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole | Ki | 4.57 [1], 4.6 [2] |
 | 6-(Benzyloxy)-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole | Ki | 0.88 [1], 0.89 [2], 0.9 [3] |
 | 5-(4-Chlorophenyl)-N'-methyl-4-phenyl-N-piperidin-1-ylsulfonyl-3,4-dihydropyrazole-2-carboximidamide | Ki | 1321.0 [1] |
 | N-Cyclohexyl-1-(3,4-dichlorophenyl)-4-methyl-5-pyrrol-1-ylpyrazole-3-carboxamide | IC50 | 2.2 [1] |
| N-Cyclohexyl-1-(3,4-dichlorophenyl)-4-methyl-5-pyrrol-1-ylpyrazole-3-carboxamide | Ki | 1.7 [1] |
 | 6-Methoxy-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-ol | Ki | 0.69 [1], 0.7 [2] |
 | 1-(Oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indol-5-amine | Ki | 9.0 [1], 9.3 [2], 9.33 [3] |
 | 1-(Oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole-5-carbonitrile | Ki | 30.0 [1], 30.2 [2] |
 | 5-(Methoxymethyl)-1-(oxan-4-ylmethyl)-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole | Ki | 25.0 [1], 25.7 [2], 26.0 [3] |
 | 1-(Oxan-4-ylmethyl)-6-phenyl-3-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-indole | Ki | 0.4 [1], 0.41 [2] |
 | (6Ar,10aR)-6,6,9-trimethyl-3-(2-thiophen-2-ylpropan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | Ki | 0.27 [1], 0.91 [2] |
 | 2,2,3,3-Tetramethyl-N-(4-methyl-3-(morpholinosulfonyl)phenyl)cyclopropanecarboxamide | Ki | 23.0 [1] |
 | 4-Methyl-3-(morpholinosulfonyl)-N-(2,2,4,4-tetramethylpentan-3-yl)benzamide | Ki | 34.0 [1] |
 | Unii-8hhx5B1WP5 | Ki | 18.0 [1] |
 | N-(1-Adamantyl)-6-(furan-2-yl)-4-oxo-1-pentylquinoline-3-carboxamide | Ki | 0.7 [1] |
 | (Z)-Methyl 2-(2-isopropylphenylimino)-5,5-dimethyl-1,3-thiazinane-3-carbodithioate | IC50 | 6.1 [1] |
| (Z)-Methyl 2-(2-isopropylphenylimino)-5,5-dimethyl-1,3-thiazinane-3-carbodithioate | Ki | 9.0 [1] |
 | (2S)-N-[6-(4-Chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydropyrano[2,3-b]pyridin-4-yl]-2-hydroxypropanamide | IC50 | 2260.0 [1], 4800.0 [2], 5310.0 [3] |
 | N-(1-Adamantyl)-2-ethyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13),11-tetraene-11-carboxamide | IC50 | 38.0 [1] |
| N-(1-Adamantyl)-2-ethyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13),11-tetraene-11-carboxamide | Ki | 6.9 [1], 7.83 [2] |
 | 1-[[1-[(4-Fluorophenyl)methyl]-2-oxo-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine-3-carbonyl]amino]cyclohexane-1-carboxylic acid | IC50 | 9.0 [1] |
| 1-[[1-[(4-Fluorophenyl)methyl]-2-oxo-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine-3-carbonyl]amino]cyclohexane-1-carboxylic acid | Ki | 16.0 [1] |
 | 1-[[1-(Cyclohexylmethyl)-2-oxo-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine-3-carbonyl]amino]cyclohexane-1-carboxylic acid | IC50 | 7.0 [1] |
| 1-[[1-(Cyclohexylmethyl)-2-oxo-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine-3-carbonyl]amino]cyclohexane-1-carboxylic acid | Ki | 6.7 [1] |
Calculator
